Patents Assigned to SENDOZ AG
  • STABLE PHARMACEUTICAL LIQUID FORMULATIONS OF THE FUSION PROTEIN TNFR:Fc
    Publication number: 20140186351
    Abstract: The present invention relates to stable pharmaceutical liquid formulations of the fusion protein TNFR:Fc comprising different buffer systems and stabilizers. In particular, it could be demonstrated that the physical stability of TNFR:Fc is significantly improved by using a citrate buffer system and lysine as stabilizer.
    Type: Application
    Filed: April 19, 2012
    Publication date: July 3, 2014
    Applicant: SENDOZ AG
    Inventors: Deutel Britta, Thomas Lauber, Sabine Fuertinger